You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華康股份(605077.SH):擬以2197.644萬元認購寧波中藥定向發行的851.8萬股
格隆匯 01-07 16:23

格隆匯1月7日丨華康股份(605077.SH)公佈,公司於2022年1月6日與寧波中藥和方明簽訂《股票發行認購合同》,擬以2197.644萬元人民幣認購寧波中藥定向發行股票851.8萬股。

寧波中藥所處行業為生物醫藥製造業,主營業務為中藥原料藥、天然植物提取物及功能性食品、保健品的研發、生產、銷售,由創建1956年的國字號老牌中藥企業“寧波中藥製藥廠”改制而成。

寧波中藥目前主要系列產品有:天然色素(以薑黃色素為主導)、天然營養及藥用提取物(黃素、低酸銀杏葉提取物、無農殘人蔘提取物、葡萄籽提取物、槲皮素、黃連素、石杉鹼甲、左旋多巴、白藜蘆醇、蘋果醋等)、高倍甜味劑(二氫查爾酮、羅漢果提取物等)、生粉類(薑黃粉、魔芋粉、生薑粉、肉桂粉等)。

此次交易是基於上市公司經營發展需要做出的決策,有利於優化資源整合,實現健康發展。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account